New drug preparations used for treating congestive heart failure: converting enzyme inhibitors, nitroprusside, nitrates and calcium channel blockers
Rudolf, W.; Froer, K.L.; Hall, D.
Terapevticheskii Arkhiv 54(11): 110-112
1982
ISSN/ISBN: 0040-3660 PMID: 6186040 Document Number: 185411
Document emailed within 1 workday
Related Documents
Sinaiko, A.R. 1994: Clinical pharmacology of converting enzyme inhibitors, calcium channel blockers and diuretics Journal of Human Hypertension 8(5): 389-394Wiecek, A. 1992: Effect of calcium channel blockers and angiotensin i converting enzyme inhibitors on the kidney Polski Tygodnik Lekarski 47(49-50): 1115-1117
Sami, M.H. 1994: Distinctive properties of perindopril among converting enzyme inhibitors in congestive heart failure Canadian Journal of Cardiology 10 Suppl D: 13d-16d
Kolber-Postepska, B. 1992: Treatment of chronic congestive heart failure using angiotensin converting enzyme inhibitors Wiadomosci Lekarskie 45(23-24): 903-906
Thilly, N.; Zannad, Fïez.; Dufay, E.; Juillière, Y.; Briançon, S. 2003: Angiotensin-converting enzyme inhibitors in congestive heart failure: clinical practice guidelines Therapie 58(4): 341-349
Ghali, J.K.; Giles, T.; Gonzales, M.; Horswell, R.; Kumar, S.; Lejuene, A.; Livaudais, G.F.; Sarkar, I.C. 1997: Patterns of physician use of angiotensin converting enzyme inhibitors in the inpatient treatment of congestive heart failure Journal of the Louisiana State Medical Society: Official Organ of the Louisiana State Medical Society 149(12): 474-484
Nony, P.; Boissel, J.P.; Girard, P.; Leizorovicz, A.; Lievre, M.; Chifflet, R. 1992: Relative efficacy of angiotensin converting enzyme inhibitors on mortality of patients with congestive heart failure: implications of randomized trials and role of the aetiology (ischaemic or non-ischaemic) of heart failure European Heart Journal 13(8): 1101-1108
Squire, I.B.; MacFayden, R.J.; Reid, J.L.; Devlin, A.; Lees, K.R. 1996: Differing early blood pressure and renin-angiotensin system responses to the first dose of angiotensin-converting enzyme inhibitors in congestive heart failure Journal of Cardiovascular Pharmacology 27(5): 657-666
Clara, J.G. 1989: Congestive heart insufficiency and angiotensin converting enzyme inhibitors Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de Cardiologia 8(7-8): 553-557
Chourashy, B.K. 1988: Anti-anginal drugs: calcium channel blockers, beta-adrenergic blockers and nitrates Journal of the Indian Medical Association 86(10): 274-276
McMurray, J.J. 1998: Failure to practice evidence-based medicine: why do physicians not treat patients with heart failure with angiotensin-converting enzyme inhibitors? European Heart Journal 19(Suppl): L15-L21
Wang, L-chun.; Ma, H.; He, J-gui.; Liao, X-xue.; Chen, W-fang.; Leng, X-yu.; Ma, L.; Mai, W-yi.; Tao, J.; Zeng, W-tao.; Liu, J.; Dong, Y-gang.; Tang, A-li.; Feng, C. 2005: Effect of angiotensin converting enzyme inhibitor on the calcium transients and calcium handling proteins in ventricular myocytes from rats with heart failure Chinese Medical Journal 118(9): 731-737
Zannad, F. 1992: Management of the treatment with converting enzyme inhibitors in chronic heart failure La Revue du Praticien 42(20): 2563-2567
Arslanagić, A.; Raljević, E. 1999: Converting enzyme inhibitors in acute myocardial infarct and heart failure Medicinski Arhiv 53(1): 29-31
Guazzi, M.D.; Berti, M.; Dardani, M.; Muratori, E.; Guazzi, M. 1989: Two sides of the coin, or converting enzyme inhibitors in the therapy of heart failure Cardiologia 34(1): 15-18
Olinic, N.; Vida-Simiti, L.; Cristea, A.; Mureşan, A.; Pop, S.; Teşanu, E. 1994: Correlation between fibronectin and cardiothoracic ratio in heart failure treated with angiotensin converting enzyme inhibitors Romanian Journal of Internal Medicine 32(4): 253-257
Cody, R.J.; Laragh, J.H.; Atlas, S.A.; Case, D.B. 1983: Converting enzyme inhibition to identify and treat renin-mediated or sodium-volume related forms of increased peripheral resistance in hypertension and in congestive heart failure Journal of Hypertension. Suppl: Official Journal of the International Society of Hypertension 1(1): 77-84
Tsuyuki, R.T.; Yusuf, S.; Rouleau, J.L.; Maggioni, A.P.; McKelvie, R.S.; Wiecek, E.M.; Wang, Y.; Pogue, J.; Teo, K.K.; White, M.; Avezum, A.; Latini, R.; Held, P.; Lindgren, E.; Probstfield, J. 1997: Combination neurohormonal blockade with ACE inhibitors, angiotensin Ii antagonists and beta-blockers in patients with congestive heart failure: design of the Randomized Evaluation of Strategies for Left Ventricular Dysfunction (RESOLVD) Pilot Study Canadian Journal of Cardiology 13(12): 1166-1174
Caldwell, B.V. 1993: Treating hypertension in the diabetic patient: therapeutic goals and the role of calcium channel blockers Clinical Therapeutics 15(4): 618
Gheorghiade, M.; Hall, V.B.; Jacobsen, G.; Alam, M.; Rosman, H.; Goldstein, S. 1995: Effects of increasing maintenance dose of digoxin on left ventricular function and neurohormones in patients with chronic heart failure treated with diuretics and angiotensin-converting enzyme inhibitors Circulation 92(7): 1801-1807